S90652 in Paediatric Hypertension

Servier

Status and phase: Completed; Phase 2

Conditions: Hypertension

Treatments: Drug: Perindopril

Study type: Interventional

Funder types: Other

Identifiers

NCT00202553

CL2-90652-001

Details and patient eligibility

About

The aim of the study is to assess the acceptability, safety and pharmacokinetics and effects on blood pressure of a paediatric formulation of perindopril given in hypertensive children

Enrollment: 50 estimated patients

Sex: All

Ages: 2 to 16 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hypertensive children

Exclusion criteria

• Renal failure
• Unstable renal function
• Hyperkaliemia

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)